LeonaBio
Share
Today marks an important milestone for our company.
Athira Pharma is now LeonaBio, Inc., reflecting a transformative new chapter following our acquisition of rights to lasofoxifene, a Phase 3 program in metastatic breast cancer. Along with our new name, our Nasdaq ticker will change to LONA, effective January 12, 2026.
We remain dedicated to advancing innovative therapies for patients with serious diseases and high unmet medical need.
Read the full announcement here: https://investors.athira.com/static-files/5a0c261e-d22b-4af9-87c7-bc15bda7315b
This Friday, join us at the Alzheimer's Association, Orange County Chapter Research Advances event bringing together caregivers, patients, families, researchers, and healthcare professionals to learn about the latest in and dementia research.
Thank you to the Alzheimer’s Association for hosting this informative event to drive and educate on global research initiatives - we’re honored to be a presenting sponsor supporting this cause.
Register at no cost: https://alzassociationoc.wixstudio.io/research-advances
08/20/2024
Our Phase 2/3 LIFT-AD Study is evaluating the safety and efficacy of for the treatment of mild-to-moderate Alzheimer’s disease. Hear more on our company progress from CEO Mark Litton, Ph.D. as we approach our topline data readout of the clinical trial.
Learn more about : https://bit.ly/3zmY3Ip
08/12/2024
With multiple key data readouts expected, the space is poised for significant developments in the second half of 2024. In her recent BioSpace article, Heather McKenzie summarizes the highly anticipated neurological disease data readouts, including our LIFT-AD Phase 2/3 topline results of as a potential differentiated Alzheimer’s treatment.
Access the full article:
5 Neuro Data Readouts to Watch in the Second Half of 2024 After a busy first half of 2024, several companies are expecting key data readouts in the neuropsychiatric and neurodegenerative disease spaces during the next six months.
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
18706 North Creek Parkway, Suite 104
Seattle, WA
98011
